Lung Cancer, Small Cell Clinical Trial
Official title:
An Open Label, Multi-centre, Non-interventional Post-marketing Surveillance (PMS) to Monitor the Safety and Effectiveness of HYCAMTIN Administered in Korean Patients According to the Prescribing Information
Non-interventional, open-label, single group, multicentric post-marketing surveillance to monitor the safety and effectiveness of Topotecan administered in Korean patients according to the prescribing information
Non-interventional, open-label, single group, multicentric post-marketing surveillance to
monitor the safety and effectiveness of Topotecan administered in Korean patients according
to the prescribing information
Topotecan will be administered as described the prescribing information or by physician's
decision.
;
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00046111 -
A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors
|
Phase 1 | |
| Enrolling by invitation |
NCT06293833 -
Implementation of Lung Cancer Screening in the First Line Zone of ZORA (Flanders), Using a Low Dose CT-scan
|
N/A | |
| Completed |
NCT00259935 -
A Study To Determine If Two Different Versions Of Topotecan Have The Same Potency In Patients With Advanced Solid Tumors
|
Phase 1 | |
| Active, not recruiting |
NCT04986670 -
NutriCare Plus a Medically Tailored Meal Intervention Among Patients With Lung Cancer
|
N/A | |
| Completed |
NCT00997061 -
SCOT Registry: Small Cell Lung Cancer Treatment and Outcome
|
N/A | |
| Completed |
NCT00276276 -
Active Symptom Control Alone Or In Combination With Oral Topotecan In Patients With Relapsed Resistant Small Cell Lung Cancer
|
Phase 3 | |
| Not yet recruiting |
NCT05320458 -
Pulmonary Rehabılıtatıon Wıth Non-Small Lung Cancer
|
N/A | |
| Active, not recruiting |
NCT05228496 -
A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Sitravatinib as Maintenance Therapy for ES-SCLC
|
Phase 2 | |
| Completed |
NCT00316186 -
First-line Treatment Of Subjects With Extensive Disease Small Cell Lung Cancer With Weekly Hycamtin And Paraplatin
|
Phase 2 | |
| Not yet recruiting |
NCT04440800 -
Feasibility of Wearable Activity Trackers for Detection of TOXicity in People Receiving Systemic Anticancer Treatment
|
||
| Completed |
NCT00698516 -
Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer
|
Phase 2 | |
| Terminated |
NCT03499678 -
Lung Cancer Screening Using DNA Methylation Changes in Circulated Tumor and PBMC DNA
|
||
| Terminated |
NCT01313663 -
A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population
|
Phase 2 | |
| Active, not recruiting |
NCT04660929 -
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
|
Phase 1 | |
| Completed |
NCT00043862 -
The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC)
|
Phase 2 | |
| Completed |
NCT00320359 -
Topotecan Plus Cisplatin Versus Etoposide Plus Cisplatin In 1st Line Extensive Disease Small Cell Lung Cancer
|
Phase 3 | |
| Recruiting |
NCT06228326 -
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
|
Phase 1 | |
| Completed |
NCT04314895 -
Trial of NanoPac Intratumoral Injection in Lung Cancer
|
Phase 2 |